EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Protocol for production of tonic CAR T cells with dasatinib

Léa Rosselle, Thibault Leray, Sandy Joaquina, Benjamin Caulier, Emmet McCormack, Pascal Gelebart, Sébastien Wälchli, Else Marit Inderberg

STAR Protocols · 2025-03 · 6 (1) · 103529

DOI: 10.1016/j.xpro.2024.103529 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2025-03. Verfasst von Léa Rosselle und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: lea.ro…. Hauptthemen laut MEDLINE: Dasatinib, Receptors, Chimeric Antigen, T-Lymphocytes, Cell Culture Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Barnekreftforeningen, Horizon Europe, Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DasatinibReceptors, Chimeric AntigenT-LymphocytesCell Culture TechniquesHumansFlow CytometryProtein Kinase InhibitorsCell ProliferationRetroviridaeTransduction, Genetic

Stichwörter der Autor:innen

cancercell culturehealth sciencesimmunology

Substanzen

DasatinibReceptors, Chimeric AntigenProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: lea.rosselle@rr-research.no.
  • Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Medical Faculty, University of Oslo, Oslo, Norway.
  • Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute for Cancer Research, Department of Molecular Cell Biology, Oslo University Hospital, O…
  • Department of Clinical Science, Precision Oncology Research Group, University of Bergen, 5021 Bergen, Norway; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, Norway; Centre for Cancer…
  • Department of Clinical Science, Precision Oncology Research Group, University of Bergen, 5021 Bergen, Norway; Centre for Cancer Biomarkers (CCBIO), University of Bergen, Bergen, Norway.
  • Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.

Förderung

  • Barnekreftforeningen
  • Horizon Europe
  • Norges Forskningsråd
  • EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
  • European Commission
  • Kreftforeningen
  • Horizon 2020 Framework Programme
  • South-Eastern Norway Regional Health Authority

Zitieren

APA

Rosselle, L., Leray, T., Joaquina, S., Caulier, B., McCormack, E., Gelebart, P., Wälchli, S., & Inderberg, E. M. (2025). Protocol for production of tonic CAR T cells with dasatinib. STAR Protocols, 6(1), 103529. https://doi.org/10.1016/j.xpro.2024.103529

Vancouver

Rosselle L, Leray T, Joaquina S, Caulier B, McCormack E, Gelebart P, et al. Protocol for production of tonic CAR T cells with dasatinib. STAR Protocols. 2025;6(1):103529. doi:10.1016/j.xpro.2024.103529

BibTeX
@article{Rosselle2025,
  author = {Rosselle, Léa and Leray, Thibault and Joaquina, Sandy and Caulier, Benjamin and McCormack, Emmet and Gelebart, Pascal and Wälchli, Sébastien and Inderberg, Else Marit},
  title = {Protocol for production of tonic CAR T cells with dasatinib},
  journal = {STAR Protocols},
  year = {2025},
  volume = {6},
  number = {1},
  pages = {103529},
  doi = {10.1016/j.xpro.2024.103529}
}
Kostenlos starten →